Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients.
about
Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysisGiant cell arteritis: a systematic review of the qualitative and semiquantitative methods to assess vasculitis with 18F-fluorodeoxyglucose positron emission tomographyNon-invasive imaging of vascular inflammation.Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities.Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis.Update on the management of giant cell arteritis.Giant cell arteritis: a review.Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.Diagnostic performance of ¹⁸F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis.PET in vasculitis.Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosisLower extremity vasculitis in polymyalgia rheumatica and giant cell arteritis.Successful use of tocilizumab in polymyalgic onset biopsy positive GCA with large vessel involvement.Large-vessel giant cell arteritis: a cohort study.Giant cell arteritis: Current treatment and management.Aortic ¹⁸F-FDG uptake in patients suffering from granulomatosis with polyangiitis.Effect of glucocorticoid treatment on computed tomography angiography detected large-vessel inflammation in giant-cell arteritis. A prospective, longitudinal studyPositron emission tomography scanning in anti-neutrophil cytoplasmic antibodies-associated vasculitis.Different Scoring Methods of FDG PET/CT in Giant Cell Arteritis: Need for Standardization.18F-Fludeoxyglucose PET/CT in the evaluation of large-vessel vasculitis: diagnostic performance and correlation with clinical and laboratory parameters.Temporal artery biopsy for giant cell arteritis: retrospective audit.CMR in inflammatory vasculitis.Takayasu's arteritis in a young Caucasian female: case report and review.Association of vascular physical examination findings and arteriographic lesions in large vessel vasculitis.Giant-cell arteritis without cranial manifestations: Working diagnosis of a distinct disease pattern.18F-fluorodeoxyglucose positron emission tomography and the risk of subsequent aortic complications in giant-cell arteritis: A multicenter cohort of 130 patients.Giant cell arteritis: a systemic vascular disease.PET/CT imaging in polymyalgia rheumatica: praepubic 18F-FDG uptake correlates with pectineus and adductor longus muscles enthesitis and with tenosynovitis.Current understanding and management of giant cell arteritis and polymyalgia rheumatica.Clinical utility of FDG-PET and PET/CT in non-malignant thoracic disorders.Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review.The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with takayasu arteritis.Clinical features of polymyalgia rheumatica and giant cell arteritis.PET/MR: a paradigm shift.The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseasesClinical diagnosis and management of large vessel vasculitis: giant cell arteritis.The fine line between Takayasu arteritis and giant cell arteritis.Imaging in Giant Cell Arteritis.The Role of 18F Fluorodeoxyglucose Positron Emission Tomography Scanning in the Diagnosis and Management of Systemic Vasculitis.Peripheral arterial disease in patients with giant cell arteritis: a meta-analysis.
P2860
Q26852724-4C30D9AF-46F3-4B26-89B2-C246F25CD163Q26865857-6B4187CC-8919-4F9D-9618-FD94EBA58F81Q30431621-2C11832A-933D-40FC-85C3-9510F149294CQ30843370-2985F587-50BC-42E7-8506-97CB1FD3C441Q33339299-A6C0AA7D-73B5-454D-87C9-E61489D1C537Q33605954-A5DE5267-C5F6-4FFA-AE98-20EC755D362FQ33688189-85ED80FE-DB3C-424F-87EA-C26D7C78D5E8Q33879740-0C7FB328-861C-4BFF-8A19-2580A2E1B8F7Q33895383-16DCEB7E-E75A-4407-868A-64B8F3226D4AQ33947065-68526D73-4973-4084-8CF7-643D89EC1FD8Q33956877-B7767D4C-7AA3-485B-9EA7-27345EEC25BCQ34902696-FB80E9E5-FA78-4711-A690-DF498D8F9E07Q35094621-4A04D801-DD13-4E9C-9825-775D1EF6C2D6Q35588160-F18F520D-AD60-4711-87D5-3BFDF7731A17Q35746677-B7035745-C247-4D8F-A12D-DCB0E8E9CE09Q35851713-78FA9F1F-5C77-4B51-AEC8-5B38E9F1645AQ36152152-F7CB613A-2A30-4EF7-AE56-6F1C9702226AQ36152994-E649270B-D344-4E63-A610-ED6AED685BFFQ36256143-E52DEA7A-6807-487B-A235-E786E592DFE8Q36326221-A0C07020-3363-4661-8D10-C736E249519BQ36404650-6721659B-AF7C-4CFB-9282-C23A651A35E3Q36499266-C98E52A7-2F30-4E36-BC34-5B3E3E13377DQ36900353-4A46BFD6-5101-4FD9-A59F-3C0E74E2334EQ37060366-47451AE9-8B5D-483A-8623-2A3391BEAF8DQ37077856-9329AA99-DD44-4833-A2A2-06B5425C03AEQ37077859-1FD78619-C3A4-4F1A-9ABD-78BDA4CD184BQ37204521-A037F650-F5A8-4131-B8AF-8874B0ACC39BQ37671467-37F59182-7770-4720-8A16-E433AB6CCBA4Q37803414-662044FB-3559-4BBA-A8CE-016FAA8DEF37Q37821378-D85DF305-3872-4C5C-AB00-FA4692FBE9FCQ37915349-868EEBE6-5D11-482A-AE95-612496AA6DBFQ37944499-40174A2C-68D1-4D86-A71B-EA7771B17A5AQ38028863-5C3F20A1-4138-49AF-B163-9710511B9A90Q38085153-AC9D333A-8718-4345-9686-420313B88332Q38136661-F3E719DC-F2DF-4612-A7AD-D2F17BA825C9Q38217341-0D4D0A05-4063-449E-9650-73F9792389C6Q38270416-943B9466-8C41-4EE0-AB3E-BC13305E9046Q38538201-12AD37CE-5F7D-4A36-B47B-08E861AF14D9Q38547761-4CE52C06-5135-458C-93B7-E5486F029F28Q38556149-5EFBFAE2-C8F5-4BD5-BD1E-C6FABB6F677D
P2860
Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Repetitive 18F-fluorodeoxygluc ...... spective study of 35 patients.
@ast
Repetitive 18F-fluorodeoxygluc ...... spective study of 35 patients.
@en
type
label
Repetitive 18F-fluorodeoxygluc ...... spective study of 35 patients.
@ast
Repetitive 18F-fluorodeoxygluc ...... spective study of 35 patients.
@en
prefLabel
Repetitive 18F-fluorodeoxygluc ...... spective study of 35 patients.
@ast
Repetitive 18F-fluorodeoxygluc ...... spective study of 35 patients.
@en
P2093
P356
P1476
Repetitive 18F-fluorodeoxygluc ...... spective study of 35 patients.
@en
P2093
Daniël Blockmans
Daniël Knockaert
Herman Bobbaers
Liesbet de Ceuninck
Luc Mortelmans
P304
P356
10.1002/ART.21699
P577
2006-02-01T00:00:00Z